Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 113Gynecologic 66Breast 40Gastrointestinal 27CNS 23Head & Neck 22Lymphoid 21Genitourinary 19Other solid neoplasm 17Tumor-Agnostic 8Sarcoma 8Dermatologic 4Other hematologic neoplasm 3Plasma cell 1Other neoplasm 1NET 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Thrombocytopenia 1

Interventions

fludarabine phosphate 12Whole-Body Irradiation 11Peripheral Blood Stem Cell Transplantation 11Cyclophosphamide 11Mycophenolic Acid 9fludarabine 7Cyclosporine 6Busulfan 6Tacrolimus 4Melphalan 4Filgrastim 4Cytarabine 4Cord Blood Stem Cell Transplantation 4Antilymphocyte Serum 4eltrombopag 3Flow Cytometry 3Cytogenetic Analysis 3Cyclosporins 3Alemtuzumab 3AP 1903 reagent 3romiplostim 2Transplantation 2Topotecan 2Thiotepa 2Sirolimus 2SRA737 2Radiotherapy 2Gene Expression Profiling 2Etoposide 2Decitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Carboplatin × Classical hematology × Clear all
NCT00147225 2014-05-08

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin

M.D. Anderson Cancer Center

Phase 1/2 Completed
55 enrolled 11 charts
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡